Measles vaccines.
D000367:Age Factors; D000917:Antibody Formation; D046508:Culture Techniques; D004679:Encephalomyelitis / Q000150:complications; D005260:Female; D006460:Hemolysin Proteins; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007223:Infant; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D008458:Measles Vaccine / Q000009:adverse effects / Q000592:standards; D011247:Pregnancy; D012640:Seizures / Q000139:chemically induced; D013344:Subacute Sclerosing Panencephalitis / Q000150:complications; D013997:Time Factors; D006113:United Kingdom; D005719:gamma-Globulins
D006460:Hemolysin Proteins; D008458:Measles Vaccine; D005719:gamma-Globulins